Feed aggregator

Pharma in the Courts: Takeda, AbbVie, RedHill, Pfizer and Gilead

Biospace news - Fri, 09/24/2021 - 02:00
Aside from the fraud trial of Theranos founder Elizabeth Holmes, other court-related cases are taking place, including between Takeda and AbbVie over cancer drug, Lupron.

Former Principia CEO Tapped to Lead Esker Therapeutics

Biospace news - Fri, 09/24/2021 - 02:00
Esker Therapeutics tapped Martin Babler to helm the company after founding CEO June Lee has stepped away to pursue other opportunities.

Evidence Mounting for TILs as Possible First-Line Cancer Therapy

Biospace news - Fri, 09/24/2021 - 02:00
Study: Adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TILs) is more effective in patients who have not been treated with checkpoint inhibitors than in those who have undergone one or more therapies.

Experts Recommend Taking Race Out of the Equation for Kidney Disease

Biospace news - Fri, 09/24/2021 - 02:00
The National Kidney Foundation and the American Society of Nephrology recommend removing race from the equation in the assessment of kidney disease.

Research Roundup: Promising Parkinson’s Drug in Mice and More

Biospace news - Fri, 09/24/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Top 10 US Biopharma Series A Rounds of 2021 – So Far!

Biospace news - Fri, 09/24/2021 - 02:00
The United States has seen companies launching left and right. Check out the top 10 biopharma Series A rounds in the U.S. so far this year.

BioSpace Movers & Shakers, Sept. 24

Biospace news - Fri, 09/24/2021 - 02:00
Life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

Researchers Turn Back the Clock on Heart Cells in Mice

Biospace news - Fri, 09/24/2021 - 02:00
​Researchers from the Max Planck Institute for Heart and Lung Research reportedly achieved positive results after returning adult cardiomyocytes to their fetal-like state in mouse models.

Therapy using dual immune system cells effectively controls neuroblastoma

World Pharma News - Thu, 09/23/2021 - 10:00
A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was highly effective in mice implanted with human neuroblastoma tissue, report researchers from the UNC Lineberger Comprehensive Cancer Center and the UNC School of Medicine.

FDA Gives Narrow Authorization for Pfizer-BioNTech Booster

Biospace news - Thu, 09/23/2021 - 02:00
FDA authorizes Pfizer-BioNTech COVID-19 booster shots for individuals 65 and over, those at high risk for severe disease and front-line healthcare workers.

Walmsley Targeted Again as Activists Renew Plea for New GSK CEO

Biospace news - Thu, 09/23/2021 - 02:00
GlaxoSmithKline Chief Executive Officer Emma Walmsley faces renewed calls for her ouster after Bluebell Capital Partners has taken a £10 million (about $13.7 million) stake in the company.

Cassava’s Positive New Alzheimer’s Data Meets Lukewarm Reception

Biospace news - Thu, 09/23/2021 - 02:00
Cassava Sciences announced top-line results Wednesday from a 12-month interim analysis of its Alzheimer’s drug candidate simufilam.

GenEdit Uncloaks to Solve Gene Editing “Delivery Problem”

Biospace news - Thu, 09/23/2021 - 02:00
Kunwoo Lee has uncloaked his solution to the gene-editing “delivery problem” with $26 million in Series A funds for his company, GenEdit.

Incyte on a Roll with Two FDA Wins in Two Days

Biospace news - Thu, 09/23/2021 - 02:00
The approval is based on its Phase III REACH3 trial, which evaluated Jakafi versus the best available therapy for treating chronic GVHD after allogeneic stem cell transplantation.

AstraZeneca Dives into RNA Research with VaxEquity Collaboration

Biospace news - Thu, 09/23/2021 - 02:00
AstraZeneca aims to harness VaxEquity’s saRNA platform for use with its own therapeutic programs and intends to widely use it on up to 26 different drug targets.

Biogen Reps Blacklisted from DC Neurology Centers Due to Aduhelm

Biospace news - Thu, 09/23/2021 - 02:00
The Neurology Center posted a notice, saying, “At this time, the NCPA physicians will not be recommending this treatment for any of its patients.”

Aurion Biotech CEO: “How You React Now Determines Your Next Success”

Biospace news - Thu, 09/23/2021 - 02:00
Aurion Biotech is focused on curative and restorative treatments for corneal endothelial disease.

Umbilical Cord Protein Could Increase Stroke Survival and Recovery Rates

Biospace news - Thu, 09/23/2021 - 02:00
​Scientists found recently that a naturally occurring protein from human umbilical cord blood might be the key to increasing survival and recovery rates in stroke patients.

Global Roundup: Monument Therapeutics Takes New Approach to Treat Schizophrenia

Biospace news - Thu, 09/23/2021 - 02:00
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

9 Tips for Navigating a Job Search as an Introvert

Biospace news - Thu, 09/23/2021 - 02:00
Here are tips for introverts who are trying to land their dream job.